Pharmaceuticals & Biotech

A new way to assess patient-centered investments

By Sharon Suchotliff, Michael Shaw, and Remy Friedman

Nov. 14, 2023 | Webinar | 38-minute watch

A new way to assess patient-centered investments

Just about every leader across life sciences can clearly define the ROI for any investment made by their organization. But, if you ask those same leaders about how these same solutions affect patients, the answer is not nearly as apparent. As patients increasingly expect to derive concrete value from each interaction with the healthcare system, organizations must understand how their efforts truly impact patient outcomes. Moreover, given the outsized effect of social drivers of health, recognizing disparities driven by these factors is crucial to building better, more equitable solutions.


Experts from ZS join Genentech's Laurie Meyers in a discussion on how to apply Patient Outcomes Impact (POITM) metrics to understand the impact of disease awareness campaigns.


In this webinar, you’ll learn how to:

  • Evaluate life sciences investments for meaningful differences in impact on individuals of diverse sociodemographic backgrounds
  • Assess the effect of nonpromotional teams and initiatives on patients’ lives broader than just clinical outcomes
  • Use POITM metrics to inform critical business decisions

Add insights to your inbox

We’ll send you content you’ll want to read – and put to use.

About the author(s)